High performance additive manufacturing (HPAM) and material science companyOxford Performance Materials(OPM) has partnered with advanced material supplierJSR Corporationin Tokyo to launch medical & dental operations across Asia.
Under the new partnership, JSR has an exclusive regional license to provide and distribute OPM’s PEKK based 3D printing services and consumables.
The two entities will operate together as OPM Asia, and aim to reach across 14 different regions: Japan, China, Taiwan, Korea, Brunei Darussalam, Cambodia, Lao PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam and India.
Certified 3D printed medical devices
OPM’s high performance polymer based PEKK operations are offered as the OXPEKK materials range, and the OsteoFab biomedical device 3D printing technology.
In recent years, OPM has been steadily gainingFDA certificationfor patient-specific 3D printed medical devices made from OXPEKK materials. Furthermore, hinting at the most recent move with JSR, OXPEKK technology attainedAccreditation of Foreign Medical Device Manufacturer(FMDM) from the Japanese Ministry of Health, Labour and Welfare back in March 2018.
OsteoFab, by contrast, is the engine used to 3D print medical devices from OXPEKK polymers. With this system, OPM strives to streamline the device production process, efficiently designing, manufacturing and marketing products for biomedical and dental markets.
The specific technology used for the process is selective laser sintering (SLS) on an EOSINT P800 system. Devices made using the technology have proven toimprove the osseointegration(bone on growth) of alternative mass-manufactured medical implants.
A multi-billion dollar opportunity
OPM founder and CEO Scott DeFelice will also serve as CEO of OPM Asia in this new partnership with JSR. OPM Chief Business Development Officer Bernard Plishtin and a representative of JSR will join DeFelise on company’s board of directors.
Commenting on the strategic decision, DeFelice says, “Asia’s healthcare industry is growing rapidly, and with that growth comes increased demand for medical innovation that delivers improved clinical effectiveness to more people with superior economics.”
Additionally, “…JSR will be a strong, influential partner to OPM,”
“We are extremely pleased that JSR has decided to finance the OPM Asia enterprise and work with us to establish the OPM technology platform throughout Japan and the wider region.”
According toFrost & Sullivanmarket research, Asia’s healthcare industry in expected to grow 11.1% to $517 billion by 2019.
To stay up to date with all the latest medical 3D printing movements follow3D Printing Industry on Twitter, and subscribe to ourfree additive manufacturing newsletterfor regular digests.
寻求一份新工作在3 d打印或雇佣e? Create a profile now on our3D Printing Jobssite.
Featured image shows a 3D printed skull with an OXPEKK cranial implant. Photo via Oxford Performance Materials
